A multicenter prediction model for false-positive clinical nodal disease in < 4-cm NSCLC: clinical implications for upfront surgery versus neoadjuvant therapy
{{output}}
Background: Perioperative immunochemotherapy is recommended for resectable non-small cell lung cancer (NSCLC) with ≥ 4-cm tumors or clinical nodal involvement (cN(+)). Therefore, accurate preoperative nodal assessment is crucial... ...
